# A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

> **NCT01371331** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 52 (actual)

## Conditions studied

- Kidney Transplantation
- Heart Transplantation
- Liver Transplantation

## Interventions

- **DRUG:** Tacrolimus granules

## Key facts

- **NCT ID:** NCT01371331
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-09
- **Primary completion:** 2015-02-03
- **Final completion:** 2015-02-03
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371331, "A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01371331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*